We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Pharmaceutical Certification for Cell Therapy Obtained by Bio Elpida

News   Nov 25, 2010

 
Pharmaceutical Certification for Cell Therapy Obtained by Bio Elpida
 
 
Advertisement
 

RELATED ARTICLES

Dual CAR T Cell Immunotherapy Fights HIV Infection in Humanized Mice

News

A recent study published in the journal Nature Medicine describes a new Dual CAR T cell immunotherapy that can help fight HIV infection.

READ MORE

CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity

News

New research has uncovered the presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB).

READ MORE

Collaborations Aim to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE